Objective

  • To track of competitive activity for client in the RA space. This supported client’s R&D team to strategize internal development of pipeline and commercial assets
  • Landscape report on emerging IL-6 biosimilar competitors
  • Key competitor assets in the rheumatology domain & their updates in EULAR and ACR conference

Approach

  • A team of 2 analysts were deployed to track updates of each competitor asset - monitoring key events, product profiles, competitive landscape analysis & efficacy/safety analysis of key competitors was done on regular basis
  • Conference coverage support provided to client with: conference planner, on-site coverage and post-con report

Project Illustrations

Business Impact

  • The exercise helped in identifying product strategy of key competitor companies in RA
  • Developing strategies to counter and minimize overall impact
  • Assess the potential impact caused by biosimilar entries
  • Conference coverage in the rheumatology therapy area helped the client with key scientific insights on competitor assets. This supported client’s R&D team to strategize development approach of their assets